- Reaction score
- 1,242
Since Shiseido had to do phase 2 on their own and replicel didn't share their info I think Shiseido will still be superior. Bigger company and they have their own product that can be useful for improving. They also can get faster to the market and get much more information from their product when thousands of people use it.Some random thought:
Replicel is doing a study with UCB to better understand why some patients had better results than others - based on the data from their 5 years trial. And they will use it to improve RCH-01.
Shiseido is doing phase 2 and is said they can release it to the market sometime next year, if it turns to be effective.
Must Replicel share their findings with Shiseido as per their agreement? If not, Replicel might have a better product (more effective) than Shiseido's, when (IF) they ever release it.
I think Replicel is going to wait much longer and will fill it's bank account with the contract fees from Shiseido. Let's see if they will ever bring something out on their own.
İf it just was for replicel I wouldn't wait for them, but Shiseido gives me hope
Last edited: